Stock Markets January 27, 2026

Energean posts higher Q4 output, holds revenue and dividend amid asset write-down

Company keeps 2025 sales and adjusted EBITDAX steady while flagging impairment and arbitration linked to Cassiopea asset

By Nina Shah
Energean posts higher Q4 output, holds revenue and dividend amid asset write-down

Energean plc reported a 12% year-on-year rise in fourth-quarter production to 162 kboed, supporting full-year output at the top end of guidance. The company delivered $1.72 billion in sales revenue and $1.11 billion in adjusted EBITDAX for 2025, maintained its $1.20 per share dividend and returned $221 million to shareholders, while disclosing a planned €300 million non-cash impairment at the Cassiopea asset and initiating arbitration seeking €265 million in reimbursement.

Key Points

  • Energean's Q4 production rose 12% year-on-year to 162 kboed, helping full-year output reach the upper end of guidance; full-year production averaged 154 kboed with 113 kboed from Israel operations - impacts the energy sector and oil and gas supply metrics.
  • The company reported stable 2025 sales revenue of $1.72 billion and adjusted EBITDAX of $1.11 billion despite geopolitical pressures and lower oil prices - relevant to investors and credit analysts monitoring earnings resilience.
  • Energean maintains shareholder distributions, returning $221 million in 2025 and keeping the dividend at $1.20 per share, while planning $740-800 million of 2026 capex concentrating on Israel operations - important for capital allocation and financing considerations.

Energean plc announced a stronger fourth quarter of 2025 production, posting a 12% increase year-on-year to an average of 162,000 barrels of oil equivalent per day (kboed). That performance helped the company close the year with full-year production at the upper end of its stated guidance.

For the full year 2025, Energean recorded average production of 154 kboed, of which 113 kboed were produced from its Israel operations. Sales revenue for the year was $1.72 billion and adjusted EBITDAX was $1.11 billion, figures the company said were broadly in line with the prior year despite geopolitical challenges and a softer oil price environment.


Contracts and forward cover

Management highlighted the role of long-term gas contracts in supporting resilience. Energean said it has secured in excess of $20 billion of contracted revenue over the next two decades. During 2025 the company also signed new long-term domestic gas contracts in Israel with a combined value of more than $4 billion.

Chief Executive Officer Mathios Rigas emphasized these contract flows as an underpinning of the company s earnings visibility, particularly into the medium term.


2026 guidance and planned capital deployment

Energean set production guidance for 2026 in a range of 140-150 kboed, forecasting that Israel operations will contribute 108-114 kboed of that total. The company also detailed planned development and production capital expenditure of $740-800 million for 2026, noting the majority of that spending will be directed to its Israel business.


Impairment and arbitration related to Cassiopea

Energean said it expects to record a non-cash impairment of approximately c300 million connected to its Cassiopea asset, citing performance below initial expectations. Separately, the company has started arbitration proceedings against the operator of the Cassiopea field, seeking c265 million in reimbursement for costs and lost revenues.


Capital returns and balance sheet

Shareholder returns remained intact in 2025, with the company reporting $221 million returned to shareholders and maintaining its dividend at $1.20 per share. Energean reported net debt of $3.26 billion as of December 31, 2025.

The company s update combined operational growth in the quarter with targeted capital investment and a balance-sheet that reflects both ongoing returns to shareholders and the impact of the impairment tied to Cassiopea.


Investors and market participants will be watching the implementation of the 2026 capex plan, the contribution of Israeli production to next year s volumes, and the outcome of the Cassiopea arbitration and associated accounting treatment as the company moves through the coming months.

Risks

  • A planned non-cash impairment of approximately c300 million at the Cassiopea asset reflects lower-than-expected performance and introduces headline earnings pressure - relevant to equity and accounting assessments in the energy sector.
  • Arbitration against the Cassiopea field operator seeking c265 million in reimbursement creates legal and execution uncertainty; the outcome could affect cash recovery expectations and future costs - relevant to corporate legal risk and investor returns.
  • Net debt of $3.26 billion at year-end 2025 and sizable planned 2026 capex of $740-800 million concentrate funding and execution risk, especially given the reliance on Israeli operations for a majority of near-term production - relevant to credit risk and funding-mix analysis.

More from Stock Markets

Indian equities rally after U.S. agrees tariff reductions in trade accord Feb 2, 2026 SiTime Nears Acquisition of Renesas Timing Business in Potential $3 Billion Deal Feb 2, 2026 Tesla Debuts New All-Wheel Drive Model Y Trim in U.S.; Premium Option Also Launched Feb 2, 2026 Eastroc Beverage Shares Start Trading in Hong Kong at Offer Price After $1.3 Billion IPO Feb 2, 2026 SoftBank unit and Intel to jointly develop 'Z-Angle' memory technology Feb 2, 2026